DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
O'Brien S, Furman RR, Coutre S. et al.
Single-agent ibrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience.
Blood 2018;
131: 1910-1919
We do not assume any responsibility for the contents of the web pages of other providers.